CDH2 and cancer: The TF, c-Myc, is the main driver of glutamine utilization by cancer cells, and circ_0005529 increased the expression levels of c-Myc and N-cadherin by binding to miR-527, which promoted GC cell proliferation, migration, and EMT development [163,164].